Financials
- Market Capitalization 5.31 B
- Employee 497
- Founded 2011
- CEO N/A
- Website www.travere.com
- Headquarter California, United States
- FIGI BBG000P9D6W9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-131.76
市销率
6.95
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1276 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 101.28 USD | +2.68% | +5.73% | +22.75% | +428.33% | 5.54 B USD | ||
| 1286 | CELC Celcuity Inc. - Common Stock | 111.05 USD | +6.99% | -2.59% | +25.42% | +700.65% | 5.42 B USD | ||
| 1334 | DFTX Definium Therapeutics, Inc. - Common Shares | 45.98 USD | +5.34% | +2.47% | +94.42% | +204.30% | 5.01 B USD | ||
| 1361 | CRSP CRISPR Therapeutics AG - Common Shares | 50.46 USD | -0.34% | -13.80% | -4.25% | -5.58% | 4.87 B USD |